SCHEMBL24745569

SCHEMBL24745569

COC(=O)c1cc(F)c(OCC(=O)OC(C)(C)C)cc1CBr

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 5/20 0.42
▸ MTNR1B P49286 5/20 0.42
▸ AAK1 Q2M2I8 3/20 0.39
▸ PSEN1 P49768 1/20 0.36
▸ PSEN2 P49810 1/20 0.36
▸ APH1B Q8WW43 1/20 0.36
▸ NCSTN Q92542 1/20 0.36
▸ APH1A Q96BI3 1/20 0.36
▸ PSENEN Q9NZ42 1/20 0.36
▸ HMGCR P04035 1/20 0.35
▸ SCN9A Q15858 2/20 0.34
▸ HPGD P15428 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24745568 0.84 HPGD (0.39) MTNR1AMTNR1BAAK1PSEN1PSEN2
SCHEMBL24744883 0.79 MTNR1A (0.34) MTNR1AMTNR1BPSEN1PSEN2APH1B
SCHEMBL24817922 0.78 DRD2 (0.35) MTNR1AMTNR1BKDM4EALDH1A1GAA
SCHEMBL27974 0.76 DPP4 (0.41) HPGDKDM4EALDH1A1HSD17B10POLB
SCHEMBL6581250 0.75 LMNA (0.42) MTNR1AMTNR1BAAK1MAPTCYP2C9
SCHEMBL6645891 0.75 KDM4E (0.39) MTNR1AMTNR1BPSEN1PSEN2APH1B
SCHEMBL20510109 0.75 FFAR4 (0.52) MTNR1AMTNR1BPSEN1PSEN2APH1B
SCHEMBL30938988 0.75 ALDH1A1 (0.36) MTNR1AMTNR1BPSEN1PSEN2APH1B
SCHEMBL25215120 0.75 KCNA5 (0.39) MTNR1AMTNR1BAAK1
SCHEMBL24744882 0.74 ALDH1A1 (0.37) MTNR1AMTNR1BPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4347579-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN Captor Therapeutics S.A. (PL) 2024-04-10 — — EP disclosed
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 — — WO disclosed
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 — — WO disclosed
Send feedback